Cardiovascular Risk Factor Clinical Trial
— BELLUGATOfficial title:
Supervised Physical Exercise and Lifestyle Counselling in the Management of Metabolic Risk in Low-active Adults; a Controlled Randomized Trial. Belluga't de CAP a Peus
Verified date | August 2019 |
Source | INEFC-Lleida |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is evaluate the effectiveness of different doses of supervised
exercise training intensity -concomitant to lifestyle counselling- as a Primary Health Care
intervention tool for the management of the metabolic syndrome in low active adults with one
or more metabolic risk factors.
Secondary aims of the study are to investigate the effects of these interventions on systemic
inflammation and adipose tissue function, cardiorespiratory fitness, physical activity and
sedentary habits, and the cost-effectiveness of the intervention with regard to health
related quality of life.
The general hypothesis is that adults with risk factors for metabolic syndrome participating
in interventions for the promotion of a healthy lifestyle that together with counselling
strategies will include supervised physical exercise of vigorous intensity will present
greater improvements in terms of metabolic risk, physical condition, physical
activity/sedentary behaviours and psychological parameters at the end of the intervention and
at 6-months follow-up than participants in interventions for the promotion of a healthy
lifestyle that will include counselling plus physical exercise of low-to-moderate intensity
or interventions based exclusively on counselling.
It is a three arms controlled randomized clinical trial implemented in the Primary Health
Care setting and of 10 months duration.
Status | Completed |
Enrollment | 77 |
Est. completion date | December 31, 2017 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 52 Years |
Eligibility |
Inclusion Criteria: - Low active (achieving less than 150 minutes/week of moderate-to-vigorous physical activity or have not participated in any supervised exercise programs for at least the last 6 months). - Having one or more risk factors for metabolic syndrome (Marcuello et al., 2013) (waist circumference >94.5 cm for men and >89.5 cm for women; blood pressure =130/85 mmHg; triglycerides in plasma =150 mg/dL; high density lipoprotein cholesterol in plasma <40 mg/dL for men and <50 mg/dL for women; fasting glycaemia =100 mg/dL). - Accept and sign the written informed consent. - Accept the randomized group assignment. Exclusion Criteria: - Couples or individuals living in the same house - Morbid obesity (BMI = 40). - A past/current history and/or physical examination or laboratory findings of significant diseases of cardiovascular, respiratory, neuromuscular, psychiatric diseases/disorders. - Diseases/disorders that may contraindicate performing physical exercise or a stress test. |
Country | Name | City | State |
---|---|---|---|
Spain | INEFC-Lleida | Lleida |
Lead Sponsor | Collaborator |
---|---|
INEFC-Lleida | Institut Català de la Salut, Jordi Gol i Gurina Foundation, Universitat de Lleida |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cost-effectiveness of the intervention | Direct and indirect costs of setting and running the interventions will be collected for the economic evaluation analysis by means of questionnaires. HRQoL scores will be used to weight survival years and generate quality adjusted life years (QALYs ). The cost-effectiveness analysis will be conducted according to the current practice methods for economic evaluation (Frew et al., 2014). | 4 months | |
Primary | Change from baseline in metabolic risc score | A continuous metabolic syndrome risk score (cMSSy) will be calculated as described by Wijndaele (Wijndaele et al., 2006). The score contains the five risk factors considered in the definition of the metabolic syndrome (Expert panel on detection, 2001; Marcuello et al., 2013), that is waist circumference, triglycerides, high density lipoproteins cholesterol, systolic blood pressure and plasma glucose. | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in cardiorespiratory fitness | Improvement of peak oxygen uptake (VO2peak). Cardiorespiratory fitness will be assessed by means of voluntary maximal graded exercise on a cycle ergometer while measuring oxygen consumption (VO2). | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in active lifestyle | Daily time spent at moderate-to-vigorous physical activity. Participants will wear Actigraph accelerometers (GT3X+ models) during all day for seven consecutive days. Cut points for moderate-to-vigorous physical activity will be set above 2020 counts per minute. | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in sedentary time | Reduction of the daily time devoted to sedentary conducts. Participants will wear Actigraph accelerometers (GT3X+ models) during all day for seven consecutive days. Cut points for sedentary conducts will be set under 100 counts per minute. | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in dietary habits | Improvement of healthy eating index | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in physical activity self-efficacy questionnaire | Spanish version of the physical activity scale (Fernández-Cabrera, Medina, Rueda, Ordoñez, & León, 2012) | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in empowerment | Health Empowerment Scale (HES) (Serrani, 2014) | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in health related quality of life at the end of the intervention | Quality of life questionaire (EQ-5D) | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in health related quality of life | Quality of life questionaire (EQ-5D) | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in interleucin-6 | Fasting blood samples will be drawn to determine interleukin by cytometry. | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in adiponectin | Fasting blood samples will be drawn to determine adiponectin by cytometry. | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. | |
Secondary | Change from baseline in plasma metabolome | Fasting blood samples will be drawn to determine plasma metabolome. | 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04481503 -
Transthoracic Echocardiography of Ventricular Function of Parturients in Labor
|
||
Terminated |
NCT04088240 -
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
|
N/A | |
Completed |
NCT03410342 -
The Effects of Types of Fruits and Vegetables on Vascular Function
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Recruiting |
NCT04231838 -
Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT04562467 -
The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
|
Phase 4 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT04551872 -
RESILIENCE: Personalizing Cardiovascular Health
|
N/A | |
Enrolling by invitation |
NCT03314818 -
Natural History of Carotid Plaque as Determined by 3D Ultrasound
|
N/A | |
Completed |
NCT03060811 -
Mediterranean Diet, Trimethylamine N-oxide (TMAO) and Anti-oxidants in Healthy Adults
|
N/A | |
Completed |
NCT04279704 -
Overcoming Obstacles in Epigenetic Analysis of Human Twins
|
||
Completed |
NCT01050205 -
The Healthy Lifestyle Project
|
N/A | |
Completed |
NCT03570840 -
Pediatric Metabolic Syndrome Study
|
||
Completed |
NCT03039023 -
Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans
|
N/A | |
Completed |
NCT03646175 -
Choline Supplementation and Cardiovascular Health
|
N/A |